tiprankstipranks
Plus Therapeutics Inc (PSTV)
NASDAQ:PSTV
Holding PSTV?
Track your performance easily

Plus Therapeutics (PSTV) Income Statement

561 Followers

Plus Therapeutics Income Statement

Last quarter (Q3 2024), Plus Therapeutics's total revenue was $1.46M, a decrease of -21.47% from the same quarter last year. In Q3, Plus Therapeutics's net income was $-2.87M. See Plus Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 4.41M$ 4.91M$ 224.00K$ 6.00K$ 303.00K-
Cost of Revenue
------
Gross Profit
$ 5.65M$ 4.91M$ 224.00K$ 6.00K--
Operating Expense
$ 19.70M$ 13.32M$ 19.71M$ 12.49M$ 9.89M$ -10.65M
Operating Income
$ -14.05M$ -13.32M$ -19.71M$ -12.49M$ -9.58M$ -3.66M
Net Non Operating Interest Income Expense
$ 190.00K$ 5.00K$ -564.00K$ -913.00K$ -1.05M$ -3.03M
Other Income Expense
$ -5.65M-$ 1.00K$ 60.00K$ -2.40M$ -3.41M
Pretax Income
$ -8.20M$ -13.32M$ -20.27M$ -13.40M$ -8.23M$ -3.28M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
---$ 6.00K--
Net Income Common Stockholders
$ -12.29M$ -13.32M$ -20.27M$ -13.40M$ -8.24M$ -19.05M
Basic EPS
$ -2.57$ -4.24$ -11.55$ -16.65$ -27.90-
Diluted EPS
$ -2.83$ -4.24$ -11.55$ -16.65$ -27.90-
Basic Average Shares
$ 21.90M$ 3.14M$ 1.75M$ 805.95K$ 295.19K$ 92.27K
Diluted Average Shares
$ 26.15M$ 3.14M$ 1.75M$ 805.95K$ 295.19K-
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 19.70M$ 13.32M$ 19.71M$ 12.49M$ 9.89M$ -10.65M
Net Income From Continuing And Discontinued Operation
$ -12.29M$ -13.32M$ -20.27M$ -13.40M$ -8.24M$ -10.89M
Normalized Income
$ -1.70M--$ -10.52M--
Interest Expense
------
EBIT
$ -12.15M$ -12.92M$ -19.56M$ -12.47M$ -7.13M$ -1.43M
EBITDA
$ -11.26M$ -12.29M$ -18.95M$ -12.07M$ -6.77M$ 18.00K
Currency in USD

Plus Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis